SILO PHARMA, INC. Class of Warrant or Right, Outstanding
SILO PHARMA, INC. (SILO) had Class of Warrant or Right, Outstanding of 34.04 thousand shares as of 2025-12-31, per its POS AM filed 2026-04-14.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-13
- 2025-12-31: Class of Warrant or Right, Outstanding 34.04K shares.
- 2025-10-31: Class of Warrant or Right, Outstanding 190.48K shares; Class of Warrant or Right, Outstanding as first filed 2.86M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 70.67K shares; Class of Warrant or Right, Outstanding as first filed 34.04K shares.
- 2025-08-31: Class of Warrant or Right, Outstanding 70.67K shares; Class of Warrant or Right, Outstanding as first filed 1.06M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 34.04K shares POS AM · filed 2026-04-14 | |
| 2025-10-31 | 190.48K shares 10-Q · filed 2026-08-13 | 2.86M shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 70.67K shares 10-Q · filed 2026-08-13 | 34.04K shares 10-Q · filed 2025-11-13 |
| 2025-08-31 | 70.67K shares 10-Q · filed 2026-08-13 | 1.06M shares 10-Q · filed 2026-05-14 |
| 2025-06-30 | 34.04K shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 34.04K shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 34.04K shares 10-K · filed 2025-03-28 | |
| 2024-09-30 | 34.04K shares 10-Q · filed 2024-11-12 | |
| 2024-07-18 | 763.64K shares POS AM · filed 2026-04-14 | |
| 2024-06-30 | 34.04K shares 10-Q · filed 2024-08-13 | |
| 2024-06-04 | 34.04K shares 10-Q · filed 2025-05-09 | |
| 2024-04-23 | 68.81K shares POS AM · filed 2026-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |